BIIB
28
2
BMY
58
5
LMT
32
-12
KO
44
2
GILD
49
2
AA
60
9
TROW
51
3
CPB
24
2
JWN
42
2
AFL
49
3
ADI
47
2
AEP
53
2
LB
41
7
HBAN
56
2
UA
59
14
MLM
51
3
PH
73
3
CVX
44
-2
DD
60
4
NKE
30
2
BIIB
28
2
BMY
58
5
LMT
32
-12
KO
44
2
GILD
49
2
AA
60
9
TROW
51
3
CPB
24
2
JWN
42
2
AFL
49
3
ADI
47
2
AEP
53
2
LB
41
7
HBAN
56
2
UA
59
14
MLM
51
3
PH
73
3
CVX
44
-2
DD
60
4
NKE
30
2
Financhill
Back

Assembly Biosciences 10K Form

Sell
38

ASMB
Assembly Biosciences

Last Price:
14.80
Seasonality Move:
9.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-15.24M
Price / Cash Flow: 3.67
Annual Sales: $4.09
Price / Book: 3.6

Profitability

EPS (TTM): -6.92000
Net Income (TTM): $-40.8M
Gross Margin: $0
Return on Equity: -115.86%
Return on Assets: -38.94%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.36
Quick Ratio: 2.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
38
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?